2-(piperidin-4-yloxy)quinoxaline hydrochloride, 98+% C13H16ClN3O, MW: 265.74
2-(piperidin-4-yloxy)quinoxaline hydrochloride, 98+% C13H16ClN3O, MW: 265.74(1185309-98-1)
- Name: 2-(piperidin-4-yloxy)quinoxaline hydrochloride, 98+% C13H16ClN3O, MW: 265.74
- Synonyms:2-(piperidin-4-yloxy)quinoxaline hydrochloride, 98+% C13H16ClN3O, MW: 265.74;2-(4-Piperidinyloxy)quinoxaline hydrochloride
- Molecular Formula:C13H15N3O.HCl
- Molecular Weight:265.74
- CAS Registry Number:1185309-98-1
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.1185309-98-1 2-(piperidin-4-yloxy)quinoxaline hydrochloride
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.1185309-98-1 2-(piperidin-4-yloxy)quinoxaline hydrochloride, 98+% C13H16ClN3O, MW: 265.74
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:2-(piperidin-4-yloxy)quinoxaline hydrochloride, 98+% C13H16ClN3O, MW: 265.74
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.1185309-98-1 2-(Piperidin-4-yloxy)quinoxaline hydrochloride
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal Chemistry Biomedicine Pharmaceutical intermediates Chemistry experiment Biological experiments Chemical reagent For R&D use only.
Min. Order:10Milligram
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)] - Hangzhou Hysen Pharma co.,Ltd.
Other Product
- 939986-43-3/3-(3-Chloro-quinoxalin-2-yloxyMethyl)-piperidine-1-carboxylic acid tert-butyl ester, 98+% C19H24ClN3O3, MW: 377.87
- 1185307-21-4/4-AMino-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-3'-carboxylic acid Methyl ester dihydrochloride, 98+% C12H19Cl2N3O2, MW: 308.21
- 1065483-94-4/[1-(1-Ethyl-1H-benzoiMidazol-2-yl)-piperidin-3-yl]-Methanol, 98+% C15H21N3O, MW: 259.35
- 1065483-91-1/1-(1-Ethyl-1H-benzoiMidazol-2-yl)-piperidin-3-ol, 98+% C14H19N3O, MW: 245.33
- 939986-62-6/3-(3-Chloro-quinoxalin-2-yloxy)-piperidine-1-carboxylic acid tert-butyl ester, 98+% C18H22ClN3O3, MW: 363.84
- 1065483-90-0/1-(1-Ethyl-1H-benzoiMidazol-2-yl)-piperidin-4-ol, 98+% C14H19N3O, MW: 245.33
- 939986-42-2/4-(3-Chloro-quinoxalin-2-yloxy)-piperidine-1-carboxylic acid tert-butyl ester, 98+% C18H22ClN3O3, MW: 363.84
- 1146080-28-5/1-[1-(Toluene-4-sulfonyl)-1H-benzoiMidazol-2-yl]-piperidin-3-ol, 98+% C19H21N3O3S, MW: 371.46
- 1146080-06-9/3-[4-(Morpholine-4-carbonyl)-phenoxy]-piperidine-1-carboxylic acid tert-butyl ester, 98+% C21H30N2O5, MW: 390.48
- 1185319-90-7/Piperidin-4-ylMethyl-[1-(toluene-4-sulfonyl)-1H-benzoiMidazol-2-yl]-aMine hydrochloride, 98+% C20H25ClN4O2S, MW: 420.96
- 1146080-05-8/4-[4-(Morpholine-4-carbonyl)-phenoxy]-piperidine-1-carboxylic acid tert-butyl ester, 98+% C21H30N2O5, MW: 390.48
- 1146080-02-5/4-[2-(Morpholine-4-carbonyl)-phenoxy]-piperidine-1-carboxylic acid tert-butyl ester, 98+% C21H30N2O5, MW: 390.48
- 1185308-14-8/Piperidin-3-ylMethyl-[1-(toluene-4-sulfonyl)-1H-benzoiMidazol-2-yl]-aMine hydrochloride, 98+% C20H25ClN4O2S, MW: 420.96
- 1185309-92-5/Piperidin-4-yl-[1-(toluene-4-sulfonyl)-1H-benzoiMidazol-2-yl]-aMine hydrochloride, 98+% C19H23ClN4O2S, MW: 406.94
- 12768-45-5/SODIUM DODECYL SULFATE
- 1185319-71-4/4-(2-Methyl-5-phenyl-pyrrol-1-yl)-piperidine hydrochloride, 98+%
- 1185319-66-7/4-(2-Methyl-5-phenyl-pyrrol-1-ylMethyl)-piperidine hydrochloride, 98+%
- 1185318-18-6/tert-butyl-4-(3-(cyclopropylaMino)quinoxalin-2-yloxy)piperidine-1-carboxylate, 98+% C21H28N4O3, MW: 384.47
- 1185313-33-0/2-(piperidin-3-ylMethoxy)quinoxaline hydrochloride, 98+% C14H18ClN3O, MW: 279.77
- 1185309-98-1/2-(piperidin-4-yloxy)quinoxaline hydrochloride, 98+% C13H16ClN3O, MW: 265.74
- 1185319-99-6/Piperidin-3-ylMethyl-quinoxalin-2-yl-aMine hydrochloride, 98+% C14H19ClN4, MW: 278.79
- 1065484-43-6/[1-(3-Methoxy-quinoxalin-2-yl)-piperidin-3-yl]-carbaMic acid tert-butyl ester, 98+% C19H26N4O3, MW: 358.44
- 1185319-96-3/N-Cyclopropyl-N'-piperidin-4-yl-quinoxaline-2,3-diaMine hydrochloride, 98+% C16H21N5, MW: 319.84
- 1185317-78-5/[3-(4-AMino-piperidin-1-yl)-quinoxalin-2-yl]-cyclopropyl-aMine hydrochloride, 98+% C16H21N5, MW: 319.84
- 1185317-72-9/1-Quinoxalin-2-yl-piperidin-4-ylaMine hydrochloride, 98+% C13H16N4, MW: 264.76
- 1185311-71-0/Piperidin-4-ylMethyl-quinoxalin-2-yl-aMine hydrochloride, 98+% C14H18N4, MW: 278.79
- 1185317-65-0/Piperidin-4-yl-quinoxalin-2-yl-aMine hydrochloride, 98+% C13H17ClN4, MW: 264.76
- 1146080-49-0/1-(3-CyclopropylaMino-quinoxalin-2-yl)-piperidin-4-ol, 98+% C16H20N4O, MW: 284.36
- 1185311-59-4/(3-Chloro-quinoxalin-2-yl)-piperidin-3-yl-aMine hydrochloride, 98+% C13H16Cl2N4, MW: 299.20
- 1146080-45-6/(1-Quinoxalin-2-yl-piperidin-3-yl)-Methanol, 98+% C14H17N3O, MW: 243.31